Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials. Eikelboom JW, Mundl H, Alexander JH, Caso V, et al. J Am Coll Cardiol 2024;83:669-678.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Eikelboom JW, Mundl H, Alexander JH, Caso V, et al. Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials. J Am Coll Cardiol 2024;83:669-678.
PMID: 38325992